The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Eisai
Biomarker results and preclinical rationale for combination lenvatinib and pembrolizumab in advanced endometrial carcinoma.
 
Vicky Makker
Consulting or Advisory Role - Eisai
 
Allen Lee Cohn
Honoraria - Bristol-Myers Squibb; Ipsen; Merrimack; Roche/Genentech
Speakers' Bureau - Merrimack
 
Matthew H. Taylor
Honoraria - Eisai
Consulting or Advisory Role - Eisai; Onyx
 
Yukinori Minoshima
Employment - Eisai
Stock and Other Ownership Interests - Eisai
 
Yu Kato
Employment - Eisai
Stock and Other Ownership Interests - Eisai
Research Funding - Eisai
Patents, Royalties, Other Intellectual Property - Eisai
 
Ryo Dairiki
Employment - Eisai
 
Michio Kanekiyo
Employment - Eisai
Stock and Other Ownership Interests - Eisai; Oncolys BioPharma
 
Ayako Yachie
No Relationships to Disclose
 
Kotaro Kodama
Employment - Eisai
 
Pallavi Sachdev
Employment - Eisai
 
Junji Matsui
No Relationships to Disclose
 
Yasuhiro Funahashi
Employment - Eisai
Stock and Other Ownership Interests - Eisai
Patents, Royalties, Other Intellectual Property - Eisai
 
Drew W. Rasco
Employment - START
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; TaiRx, Inc.
Research Funding - Abbvie (Inst); Aeglea Biotherapeutics (Inst); Apexian Pharmaceuticals (Inst); Asana Biosciences (Inst); Ascentage Pharma (Inst); Birdie (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Eisai (Inst); Five Prime Therapeutics (Inst); Macrogenics (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Rexahn Pharmaceuticals (Inst); Santa Maria Biotherapeutics (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - Asana Biosciences